All Posts: cancer
-
Inhibiting Production of One Protein Restores Treatment Benefit in Resistant Breast Cancer
A team of investigators led by researchers at Georgetown Lombardi Comprehensive Cancer Center has found, in animal models of human breast cancer, that inhibiting a single protein restores sensitivity to tamoxifen, a commonly used drug for treatment of some breast cancers.
Category: News Release
-
Clinical Trial Underway to Test Innovative Cancer Treatment Based on Georgetown Discoveries
This August, the first patient in a multi-center clinical trial being conducted by Oncternal Therapeutics began receiving an innovative new investigational cancer therapy based on discoveries made by Toretsky, professor and leader of the molecular oncology program at the Georgetown Lombardi Comprehensive Cancer Center, and his colleagues.
Category: Lombardi Stories
-
Breast Cancer Research Championed with Avon Global Scholars, Avon Walk
May 5, 2016 — With a visit from the Avon Foundation Global Scholars Program and a team participating in Avon 39 The Walk to End Breast Cancer, supporters of Georgetown Lombardi’s breast cancer progra
Category: Lombardi Stories
-
A Cancer Survivors’ Luncheon Like No Other
(April 30, 2016) — Last year, Stanley Sher, a lawyer who lives in D.C., was certain his time was ending. “I had reached a very low, low point — three surgeries, radiation treatment and nothing had worked,” he said. “I was several months away from disappearing.” Leta Brown had a similar experience when, at age […]
Category: Lombardi Stories
-
Georgetown Lombardi Director Joins Blue Ribbon Panel Working Group For National Cancer Moonshot Initiative
April 29, 2016 — Louis M. Weiner, MD, director of the Georgetown Lombardi Comprehensive Cancer Center, has joined a blue ribbon panel-working group assembled by the National Cancer Institute (NCI) to offer expert advice on the vision, goals and implementation of the National Cancer Moonshot initiative. The NCI’s acting director Douglas R. Lowy, MD, invited […]
Category: Lombardi Stories
-
Virtual Molecular Tumor Board Brings a Collaborative Approach to Precision Medicine
(September 4, 2015) — Having to tell cancer patients there are no more treatments available for their conditions is one of the worst situations a doctor can face. However, improvements in precision medicine are helping doctors find effective therapies for even the deadliest cancers. By participating in a Virtual Molecular Tumor Board, Georgetown Lombardi is […]
Category: Lombardi Stories
-
New Clinical Trial Led by Lombardi Doctor to Compare Drug Sequences in Treatment of Melanoma
August 31, 2015 — A new nationwide clinical trial that recently opened at Georgetown Lombardi Comprehensive Cancer Center and MedStar Georgetown University Hospital will help doctors determine not only which drugs are most effective, but also how the order in which the drugs are administered affects patient outcomes. Conducted by the ECOG-ACRIN Cancer Research Group, […]
Category: Lombardi Stories
-
Lombardi Researcher Receives $6.4 Million Grant to Study Cancer and Aging
August 20, 2015 — While cancer disproportionately affects older individuals, there is relatively little research funding devoted to exploring the relationship between cancer and aging. With the support of the National Cancer Institute (NCI), Georgetown Lombardi scientist Jeanne Mandelblatt, MD, MPH, will spend seven years investigating this underdeveloped field. As the recipient of a NCI […]
Category: Lombardi Stories
-
Lombardi Scientist Receives Innovation Grant for Research on Pediatric Cancer
July 20, 2015 — There’s good news on the horizon for children battling a rare form of bone cancer. Dr. Todd Waldman, a professor of oncology at Georgetown Lombardi Comprehensive Cancer Center, has been awarded an Innovation Grant from Alex’s Lemonade Stand Foundation (ALSF) in support of his groundbreaking cancer research. At the center of […]
Category: Lombardi Stories
-
Ruesch Symposium Explores Immunotherapy and Personalized Medicine
This year’s Ruesch Symposium brought together various stakeholders in cancer medicine, including medical providers, community leaders, caregivers, and patients, to discuss the treatment landscape for patients with GI cancers.
Category: Lombardi Stories